{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:04:48Z","timestamp":1770984288628,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"China-Japan Union Hospital of Jilin University 'Green Seedling Program\u2019","award":["2024QM26"],"award-info":[{"award-number":["2024QM26"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37456-4","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:25:04Z","timestamp":1769520304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic effects of IGF-2 on NMOSD by inhibiting astrocyte apoptosis through modulation of the IGF-1R\/PI3K\/AKT signaling pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Yingyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaikai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoshuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianhui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiurong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaxin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"4","key":"37456_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon, V. A. et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202 (4), 473\u2013477 (2005).","journal-title":"J. Exp. Med."},{"issue":"2","key":"37456_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk, D. M. et al. International consensus diagnostic criteria for neuromyelitis Optica spectrum disorders. Neurology 85 (2), 177\u2013189 (2015).","journal-title":"Neurology"},{"key":"37456_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fneur.2020.00501","volume":"11","author":"JY Hor","year":"2020","unstructured":"Hor, J. Y. et al. Epidemiology of neuromyelitis Optica spectrum disorder and its prevalence and incidence worldwide. Front. Neurol. 11, 501 (2020).","journal-title":"Front. Neurol."},{"issue":"3","key":"37456_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1212\/WNL.0b013e3181e2414b","volume":"75","author":"R Takano","year":"2010","unstructured":"Takano, R. et al. Astrocytic damage is Far more severe than demyelination in NMO: a clinical CSF biomarker study. Neurology 75 (3), 208\u2013216 (2010).","journal-title":"Neurology"},{"issue":"1\u20132","key":"37456_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jns.2011.02.018","volume":"306","author":"K Fujihara","year":"2011","unstructured":"Fujihara, K. Neuromyelitis Optica and astrocytic damage in its pathogenesis. J. Neurol. Sci. 306 (1\u20132), 183\u2013187 (2011).","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"37456_CR6","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1177\/1352458510382324","volume":"16","author":"JD Parratt","year":"2010","unstructured":"Parratt, J. D. & Prineas, J. W. Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes. Mult Scler. 16 (10), 1156\u20131172 (2010).","journal-title":"Mult Scler."},{"issue":"6 Suppl 12","key":"37456_CR7","first-page":"9","volume":"27","author":"AJ Grillo-L\u00f3pez","year":"2000","unstructured":"Grillo-L\u00f3pez, A. J. Rituximab: an insider\u2019s historical perspective. Semin Oncol. 27 (6 Suppl 12), 9\u201316 (2000).","journal-title":"Semin Oncol."},{"issue":"6","key":"37456_CR8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/jnnp-2024-334764","volume":"96","author":"V H\u00e4u\u00dfler","year":"2025","unstructured":"H\u00e4u\u00dfler, V. et al. Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD. J. Neurol. Neurosurg. Psychiatry. 96 (6), 582\u2013592 (2025).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"15","key":"37456_CR9","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1212\/WNL.0b013e3182152881","volume":"76","author":"HL Pellkofer","year":"2011","unstructured":"Pellkofer, H. L. et al. Long-term follow-up of patients with neuromyelitis Optica after repeated therapy with rituximab. Neurology 76 (15), 1310\u20131315 (2011).","journal-title":"Neurology"},{"issue":"9","key":"37456_CR10","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1001\/jamaneurol.2013.3071","volume":"70","author":"SH Kim","year":"2013","unstructured":"Kim, S. H. et al. A 5-year follow-up of rituximab treatment in patients with neuromyelitis Optica spectrum disorder. JAMA Neurol. 70 (9), 1110\u20131117 (2013).","journal-title":"JAMA Neurol."},{"issue":"30","key":"37456_CR11","doi-asserted-by":"publisher","first-page":"9389","DOI":"10.1021\/bi020084j","volume":"41","author":"AM Brzozowski","year":"2002","unstructured":"Brzozowski, A. M. et al. Structural origins of the functional divergence of human insulin-like growth factor-I and insulin. Biochemistry 41 (30), 9389\u20139397 (2002).","journal-title":"Biochemistry"},{"issue":"12","key":"37456_CR12","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.3390\/cells11121886","volume":"11","author":"C S\u00e9l\u00e9nou","year":"2022","unstructured":"S\u00e9l\u00e9nou, C. et al. IGF2: Development, genetic and epigenetic abnormalities. Cells, 11(12), 1886 (2022).","journal-title":"Cells"},{"issue":"40","key":"37456_CR13","doi-asserted-by":"publisher","first-page":"34712","DOI":"10.1074\/jbc.M111.262766","volume":"286","author":"RV Iozzo","year":"2011","unstructured":"Iozzo, R. V. et al. Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling. J. Biol. Chem. 286 (40), 34712\u201334721 (2011).","journal-title":"J. Biol. Chem."},{"issue":"7","key":"37456_CR14","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1210\/jc.2002-021810","volume":"88","author":"M Bonaf\u00e8","year":"2003","unstructured":"Bonaf\u00e8, M. et al. Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control. J. Clin. Endocrinol. Metab. 88 (7), 3299\u20133304 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"37456_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1086\/506356","volume":"43","author":"AH Adewoye","year":"2006","unstructured":"Adewoye, A. H. et al. Association of polymorphisms of IGF1R and genes in the transforming growth factor- beta \/bone morphogenetic protein pathway with bacteremia in sickle cell anemia. Clin. Infect. Dis. 43 (5), 593\u2013598 (2006).","journal-title":"Clin. Infect. Dis."},{"key":"37456_CR16","doi-asserted-by":"publisher","first-page":"103730","DOI":"10.1016\/j.msard.2022.103730","volume":"60","author":"M Tahara","year":"2022","unstructured":"Tahara, M. et al. Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis Optica (RIN-2 study): B cell monitoring-based administration. Mult Scler. Relat. Disord. 60, 103730 (2022).","journal-title":"Mult Scler. Relat. Disord"},{"issue":"1","key":"37456_CR17","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12974-020-01913-2","volume":"17","author":"LW Yick","year":"2020","unstructured":"Yick, L. W. et al. Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis Optica spectrum disorders. J. Neuroinflammation. 17 (1), 236 (2020).","journal-title":"J. Neuroinflammation"},{"key":"37456_CR18","doi-asserted-by":"publisher","first-page":"134828","DOI":"10.1016\/j.neulet.2020.134828","volume":"721","author":"Y Luo","year":"2020","unstructured":"Luo, Y. et al. The developmental and experience-dependent expression of IGF-2 in mice visual cortex. Neurosci. Lett. 721, 134828 (2020).","journal-title":"Neurosci. Lett."},{"issue":"10","key":"37456_CR19","doi-asserted-by":"publisher","first-page":"105128","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105128","volume":"29","author":"F Vafaee","year":"2020","unstructured":"Vafaee, F. et al. Insulin-Like growth factor 2 (IGF-2) regulates neuronal density and IGF-2 distribution following hippocampal intracerebral hemorrhage. J. Stroke Cerebrovasc. Dis. 29 (10), 105128 (2020).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"4","key":"37456_CR20","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3390\/ijms22041849","volume":"22","author":"A Beletskiy","year":"2021","unstructured":"Beletskiy, A., Chesnokova, E. & Bal, N. Insulin-Like growth factor 2 as a possible neuroprotective agent and memory Enhancer-Its comparative Expression, processing and signaling in mammalian CNS. Int. J. Mol. Sci., 22(4), 1849 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"37456_CR21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1017\/S1041610219000383","volume":"31","author":"L Xia","year":"2019","unstructured":"Xia, L. et al. Genome-wide RNA sequencing analysis reveals that IGF-2 attenuates memory decline, oxidative stress and amyloid plaques in an alzheimer\u2019s disease mouse model (AD) by activating the PI3K\/AKT\/CREB signaling pathway. Int. Psychogeriatr. 31 (7), 947\u2013959 (2019).","journal-title":"Int. Psychogeriatr."},{"key":"37456_CR22","doi-asserted-by":"publisher","first-page":"102095","DOI":"10.1016\/j.redox.2021.102095","volume":"46","author":"E Mart\u00edn-Monta\u00f1ez","year":"2021","unstructured":"Mart\u00edn-Monta\u00f1ez, E. et al. Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of parkinson\u2019s disease. Redox Biol. 46, 102095 (2021).","journal-title":"Redox Biol."},{"key":"37456_CR23","doi-asserted-by":"crossref","unstructured":"Sep\u00falveda, D. et al. Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in Parkinson\u2019s disease. Sci. Rep., 12(1), 2038. (2022).","DOI":"10.1038\/s41598-022-05941-1"},{"key":"37456_CR24","doi-asserted-by":"publisher","first-page":"616301","DOI":"10.3389\/fimmu.2021.616301","volume":"12","author":"T Chen","year":"2021","unstructured":"Chen, T. et al. The emerging role of microglia in neuromyelitis Optica. Front. Immunol. 12, 616301 (2021).","journal-title":"Front. Immunol."},{"issue":"1","key":"37456_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12974-022-02623-7","volume":"19","author":"Y Morita","year":"2022","unstructured":"Morita, Y. et al. A novel aquaporin-4-associated optic neuritis rat model with severe pathological and functional manifestations. J. Neuroinflammation. 19 (1), 263 (2022).","journal-title":"J. Neuroinflammation"},{"key":"37456_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna, M. & Butovsky, O. Microglia function in the central nervous system during health and neurodegeneration. Annu. Rev. Immunol. 35, 441\u2013468 (2017).","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"37456_CR27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/glia.22635","volume":"62","author":"CL Howe","year":"2014","unstructured":"Howe, C. L. et al. Neuromyelitis Optica IgG stimulates an immunological response in rat astrocyte cultures. Glia 62 (5), 692\u2013708 (2014).","journal-title":"Glia"},{"issue":"4","key":"37456_CR28","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1212\/NXI.0000000000000580","volume":"6","author":"J Beekman","year":"2019","unstructured":"Beekman, J. et al. Neuromyelitis Optica spectrum disorder: patient experience and quality of life. Neurol. Neuroimmunol. Neuroinflamm. 6 (4), e580 (2019).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"issue":"2","key":"37456_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41593-018-0325-8","volume":"22","author":"M Santello","year":"2019","unstructured":"Santello, M., Toni, N. & Volterra, A. Astrocyte function from information processing to cognition and cognitive impairment. Nat. Neurosci. 22 (2), 154\u2013166 (2019).","journal-title":"Nat. Neurosci."},{"key":"37456_CR30","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3389\/fneur.2018.01104","volume":"9","author":"EB Cho","year":"2018","unstructured":"Cho, E. B. et al. White matter network disruption and cognitive dysfunction in neuromyelitis Optica spectrum disorder. Front. Neurol. 9, 1104 (2018).","journal-title":"Front. Neurol."},{"issue":"1","key":"37456_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ana.23721","volume":"73","author":"E Saji","year":"2013","unstructured":"Saji, E. et al. Cognitive impairment and cortical degeneration in neuromyelitis Optica. Ann. Neurol. 73 (1), 65\u201376 (2013).","journal-title":"Ann. Neurol."},{"issue":"10","key":"37456_CR32","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1523\/JNEUROSCI.4248-11.2012","volume":"32","author":"O Bracko","year":"2012","unstructured":"Bracko, O. et al. Gene expression profiling of neural stem cells and their neuronal progeny reveals IGF2 as a regulator of adult hippocampal neurogenesis. J. Neurosci. 32 (10), 3376\u20133387 (2012).","journal-title":"J. Neurosci."},{"issue":"6","key":"37456_CR33","doi-asserted-by":"publisher","first-page":"R321","DOI":"10.1530\/ERC-13-0231","volume":"20","author":"C Livingstone","year":"2013","unstructured":"Livingstone, C. IGF2 and cancer. Endocr. Relat. Cancer. 20 (6), R321\u2013R339 (2013).","journal-title":"Endocr. Relat. Cancer"},{"key":"37456_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.redox.2017.05.012","volume":"13","author":"E Mart\u00edn-Monta\u00f1ez","year":"2017","unstructured":"Mart\u00edn-Monta\u00f1ez, E. et al. IGF-II promotes neuroprotection and neuroplasticity recovery in a long-lasting model of oxidative damage induced by glucocorticoids. Redox Biol. 13, 69\u201381 (2017).","journal-title":"Redox Biol."},{"issue":"6","key":"37456_CR35","first-page":"499","volume":"11","author":"D \u00c5berg","year":"2021","unstructured":"\u00c5berg, D. et al. Insulin-Like growth Factor-II and ischemic Stroke-A prospective observational study. Life (Basel). 11(6), 499 (2021).","journal-title":"Life (Basel)."},{"key":"37456_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jare.2024.01.036","volume":"67","author":"SY Romero-Zerbo","year":"2025","unstructured":"Romero-Zerbo, S. Y. et al. New molecular mechanisms to explain the neuroprotective effects of insulin-like growth factor II in a cellular model of parkinson\u2019s disease. J. Adv. Res. 67, 349\u2013359 (2025).","journal-title":"J. Adv. Res."},{"issue":"6","key":"37456_CR37","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cmet.2019.01.006","volume":"29","author":"L Du","year":"2019","unstructured":"Du, L. et al. IGF-2 preprograms maturing macrophages to acquire oxidative Phosphorylation-Dependent Anti-inflammatory properties. Cell. Metab. 29 (6), 1363\u20131375e8 (2019).","journal-title":"Cell. Metab."},{"issue":"6","key":"37456_CR38","doi-asserted-by":"publisher","first-page":"e14811","DOI":"10.1111\/cns.14811","volume":"30","author":"Q Wei","year":"2024","unstructured":"Wei, Q. et al. Blood-based inflammatory protein biomarker panel for the prediction of relapse and severity in patients with neuromyelitis Optica spectrum disorder: A prospective cohort study. CNS Neurosci. Ther. 30 (6), e14811 (2024).","journal-title":"CNS Neurosci. Ther."},{"issue":"5","key":"37456_CR39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41573-022-00390-x","volume":"21","author":"HG Lee","year":"2022","unstructured":"Lee, H. G., Wheeler, M. A. & Quintana, F. J. Function and therapeutic value of astrocytes in neurological diseases. Nat. Rev. Drug Discov. 21 (5), 339\u2013358 (2022).","journal-title":"Nat. Rev. Drug Discov"},{"issue":"6","key":"37456_CR40","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","volume":"46","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. & Barres, B. A. Reactive astrocytes: Production, Function, and therapeutic potential. Immunity 46 (6), 957\u2013967 (2017).","journal-title":"Immunity"},{"issue":"1","key":"37456_CR41","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","volume":"18","author":"E Carnero Contentti","year":"2021","unstructured":"Carnero Contentti, E. & Correale, J. Neuromyelitis Optica spectrum disorders: from pathophysiology to therapeutic strategies. J. Neuroinflammation. 18 (1), 208 (2021).","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"37456_CR42","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.tins.2023.03.007","volume":"46","author":"CM Alberini","year":"2023","unstructured":"Alberini, C. M. IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases. Trends Neurosci. 46 (6), 488\u2013502 (2023).","journal-title":"Trends Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37456-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37456-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37456-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:04:11Z","timestamp":1770980651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37456-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37456"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37456-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"23 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of the China-Japan Union Hospital of Jilin University in China (Number: 2017022202). All animal experiments were performed in adherence with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the Jilin University Committee on Animal Care. All methods were carried out in accordance with relevant guidelines and regulations. All methods are reported in accordance with ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"6312"}}